|
1
|
Maher ER and Kaelin WG Jr: Von
Hippel-Lindau disease. Medicine (Baltimore). 76:381–391. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaelin WG: Von Hippel-Lindau disease. Annu
Rev Pathol. 2:145–173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Latif F, Tory K, Gnarra J, Yao M, Duh FM,
Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, et al:
Identification of the von Hippel-Lindau disease tumor suppressor
gene. Science. 260:1317–1320. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaelin WG Jr: Molecular basis of the VHL
hereditary cancer syndrome. Nat Rev Cancer. 2:673–682. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gossage L, Eisen T and Maher ER: VHL, the
story of a tumour suppressor gene. Nat Rev Cancer. 15:55–64. 2014.
View Article : Google Scholar
|
|
6
|
Sundaram C, Rammurti S, Reddy JJ, Prasad
SS and Purohit AK: Hemangioblastoma: A study of radiopathologic
correlation. Neurol India. 51:373–375. 2003.PubMed/NCBI
|
|
7
|
Lonser RR, Glenn GM, Walther M, Chew EY,
Libutti SK, Linehan WM and Oldfield EH: Von Hippel-Lindau disease.
Lancet. 361:2059–2067. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Batcher E, Madaj P and Gianoukakis AG:
Pancreatic neuroendocrine tumors. Endocr Res. 36:35–43. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee C, Park JW, Suh JH, Nam KH, et al:
Histologic variations and immunohistochemical features of
metastatic clear cell renal cell carcinoma. Korean J Pathol.
47:426–432. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takeuchi S and Takasato Y: Supratentorial
intraventricular hemangioblastomas. Acta Neurol Belg. 111:353–356.
2011.PubMed/NCBI
|
|
11
|
Johnston LB, Chew SL, Lowe D, Reznek R,
Monson JP and Savage MO: Investigating familial endocrine neoplasia
syndromes in children. Horm Res. 55(Suppl 1): S31–S35. 2001.
View Article : Google Scholar
|
|
12
|
Gaal J and de Krijger RR: Neuroendocrine
tumors and tumor syndromes in childhood. Pediatr Dev Pathol.
13:427–441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wanebo JE, Lonser RR, Glenn GM and
Oldfield EH: The natural history of hemangioblastomas of the
central nervous system in patients with von Hippel-Lindau disease.
J Neurosurg. 98:82–94. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tamura K, Nishimori I, Ito T, et al:
Diagnosis and management of pancreatic neuroendocrine tumor in von
Hippel-Lindau disease. World J Gastroenterol. 16:4515–4518. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hammel PR, Vilgrain V, Terris B, Penfornis
A, Sauvanet A, Correas JM, Chauveau D, Balian A, Beigelman C,
O'Toole D, et al: Pancreatic involvement in von Hippel-Lindau
disease. The Groupe Francophone d'Etude de la Maladie de von
Hippel-Lindau. Gastroenterology. 119:1087–1095. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chetty R, Kennedy M, Ezzat S and Asa SL:
Pancreatic endocrine pathology in von Hippel-Lindau disease: An
expanding spectrum of lesions. Endocr Pathol. 15:141–148. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blansfield JA, Choyke L, Morita SY, Choyke
PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N,
Eugeni M, et al: Clinical, genetic and radiographic analysis of 108
patients with von Hippel-Lindau disease (VHL manifested by
pancreatic neuroendocrine neoplasms (PNETs). Surgery. 142:814–818;
discussion 818.e1–e2. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mukhopadhyay B, Sahdev A, Monson JP,
Besser GM, Reznek RH and Chew SL: Pancreatic lesions in von
Hippel-Lindau disease. Clin Endocrinol (Oxf). 57:603–608. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chetty R, Kennedy M, Ezzat S and Asa SL:
Pancreatic endocrine pathology in von Hippel-Lindau disease: An
expanding spectrum of lesions. Endocr Pathol. 15:141–148. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nickerson ML, Jaeger E, Shi Y, Durocher
JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko
V, et al: Improved identification of von Hippel-Lindau gene
alterations in clear cell renal tumors. Clin Cancer Res.
14:4726–4734. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patard JJ, Shvarts O, Lam JS, Pantuck AJ,
Kim HL, Ficarra V, Cindolo L, Han KR, De La Taille A, Tostain J, et
al: Safety and efficacy of partial nephrectomy for all T1 tumors
based on an international multicenter experience. J Urol.
171:2181–2185; quiz 2435. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bratslavsky G, Liu JJ, Johnson AD,
Sudarshan S, Choyke PL, Linehan WM and Pinto PA: Salvage partial
nephrectomy for hereditary renal cancer: Feasibility and outcomes.
J Urol. 179:67–70. 2008. View Article : Google Scholar : PubMed/NCBI
|
